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Background: The antimicrobial effects of a coating of molybdenum trioxide (MoO3) has been recently described.
The metalloacid material produces oxonium ions (H3O
+), which creates an acidic pH that is an effective,
non specific antimicrobial. We determined the in vitro antimicrobial activity of molybdenum trioxide
metalloacid-coated surfaces.
Methods: Metalloacid-coated and non-coated (control) surfaces were contaminated by exposing them for
15 minutes to microbial suspensions containing 105 cfu/mL. Eleven microorganisms responsible for nosocomial
infections were tested: two Staphylococcus aureus strains (the hetero-vancomycin intermediate MRSA Mu50 strain
and a ST80-PVL-producing MRSA strain); a vancomycin-resistant vanA Enterococcus faecium strain; three
extended-spectrum beta-lactamase-producing Enterobacteriaceae strains; a MBL-producing Pseudomonas aeruginosa
strain; a multidrug-resistant Acinetobacter baumannii strain; a toxin-producing Clostridium difficile strain; and two
fungi (Candida albicans and Aspergillus fumigatus). The assay tested the ability of the coated surfaces to
kill microorganisms.
Results: Against all non-sporulating microorganisms tested, metalloacid-coated surfaces exhibited significant
antimicrobial activity relative to that of the control surfaces within two to six hours after contact with the
microorganisms (p < 0.001). Microorganism survival on the coated surfaces was greatly impaired, whereas
microorganism survival on control surfaces remained substantial.
Conclusions: We suggest that, facing the continuing shedding of microorganisms in the vicinity of colonized or
infected patients, the continuous biocidal effect of hydroxonium oxides against multidrug-resistant microorganisms
may help limit environmental contamination between consecutive cleaning procedures.
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Nosocomial infections are a major cause of patient mor-
bidity and mortality. Those associated with contaminated
surfaces and the inadequate hand hygiene of healthcare
workers (HCWs) are avoidable by cleaning and/or disin-
fecting environmental surfaces and by appropriate hygiene
practices [1-4]. The transmission of microorganisms re-
sponsible for contaminated surface-associated nosocomial
infections is well understood. Briefly, patients and HCWs* Correspondence: n.vandermee@chu-tours.fr
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reproduction in any medium, provided the orcarry and shed microorganisms around them. Surviving
microorganisms contaminate near-patient items, which
then act as reservoirs for microbial pathogens and become
sources of contamination for the hands of HCWs and of
colonization for new patients. Microbial colonization of
surfaces can be restricted by cleaning procedures that em-
ploy effective chemical products. Cleaning reduces the
prevalence of microorganisms in the environment and has
been demonstrated to be a key-measure in the control of
outbreaks associated with methicillin-resistant S. aureus
(MRSA), vancomycin-resistant enterococci (VRE) and
A. baumannii [1-7].
In fact, the continuing shedding of microorganisms
between consecutive cleansing interventions, and theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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quently result in residual environmental contamination.
An approach to reducing the levels of microbial contam-
ination on inanimate surfaces consists of using anti-
adhesive coatings to prevent microorganism adhesion
[8,9]. A second approach is to coat the surfaces of mate-
rials with disinfectants or with inorganic antimicrobials
such as silver or copper ions [10,11]. Currently being
used for catheters and dressings [12], these technologies
are now being frequently applied to other types of med-
ical equipment. The rapid release of the adsorbed bio-
cide after implantation [13], cytotoxicity on mammalian
cells [14] and the emergence of resistant microorganisms
[15] may limit the biomedical device applications of
these technologies. Zollfrank el al. recently reported the
antimicrobial effects of a newly developed antimicrobial
coating of molybdenum trioxide (MoO3) against two
reference bacterial strains, S. aureus ATCC 25923 and
Pseudomonas aeruginosa ATCC 10145 [16]. The metal-
loacid material produces oxonium ions (H3O
+), which
create an acidic pH (pH 5) that is an effective antimicro-
bial [17]. To assess the value of such coatings inTable 1 Colony counts obtained from coated and non-coated
hours
Microorganisms Colony counts in average cfu (standa
contamination with various microor
Wires 0 hr 2 hr
Pseudomonas aeruginosa coated > 2000 (nc) 1140 (89
non-coated > 2000 (nc) 1540 (89
Acinetobacter baumannii coated 1440 (89) 430 (11
non-coated 1420 (84) 1000 (0)
Escherichia coli coated > 2000 (nc) 790 (55
non-coated > 2000 (nc) 1760 (15
Klebsiella pneumoniae coated 1140 (nc) 860 (89
non-coated 1140 (114) 1040 (55
Enterobacter cloacae coated > 2000 (nc) 1940 (89
non-coated > 2000 (nc) > 2000 (nc
Mu50 Staphylococcus aureus coated 1260 (55) 438 (36
non-coated 1280 (84) 1060 (55
PVL Staphylococcus aureus coated > 1500 (nc) 770 (45
non-coated > 1500 (nc) 1240 (55
Enterococcus faecium coated 1220 (110) 124 (33
non-coated 1480 (45) 470 (76
Clostridium difficile coated 280 (45) 88 (12
non-coated 300 (0) 100 (17
Candida albicans coated 458 (62) 319 (23
non-coated 710 (86) 482 (63
Aspergillus fumigatus coated 123 (22) 101 (9)
non-coated 162 (44) 96 (18
Nc: not calculable; 1at t0 and after 2, 4, 6, 24 or 48 hours of storage, contaminated l
after incubation for 48 hours at 37°C; 2Colony counts were compared using the Wilpreventing the generation of environmental microbial
reservoirs on medical equipment and in diminishing the
risk of exposing patients to microorganisms, we studied
the biocidal activity of surfaces coated with the MoO3
metalloacid material. We tested eight multidrug-
resistant bacteria strains representative of those that
cause nosocomial infections and outbreaks worldwide, a
spore-producing, toxin-producing strain of Clostridium
difficile, and two fungi.
Methods
Microbial strains
Nine bacterial strains were used for the assay: two
MRSA strains (the Mu50 reference strain and a ST80-
PVL-producing strain); a vancomycin-resistant vanA
Enterococcus faecium strain; a toxin-producing Clostrid-
ium difficile strain, three extended-spectrum beta-lacta-
mase (ESBL)-producing Enterobacteriaceae strains
(Escherichia coli, Klebsiella pneumoniae and Enterobacter
cloacae); a MBL-producing Pseudomonas aeruginosa strain
and a MDR Acinetobacter baumannii strain. All strains ex-
cept the Mu50 strain were isolated from nosocomialsurfaces contaminated with microorganisms for 0 − 48
rd deviation) obtained from wires 0 − 48 hours after
ganisms1. Data are from five replicate experiments.
P2
4 hr 6 hr 24 hr 48 hr
) 464 (42) 114 (60) 17 (12) 2 (1)
) 1140 (167) 1060 (89) 220 (81) 33 (21) < 0.001
0) 72 (38) 69 (53) 21 (30) < 1 (nc)
590 (55) 520 (45) 67 (49) < 1 (nc) < 0.001
) 440 (47) 556 (38) 46 (8) < 1 (nc)
2) 1500 (0) 1620 (164) 90 (70) 2 (1) < 0.001
) 760 (42) 630 (60) < 1 (nc) < 1 (nc)
) 940 (55) 880 (45) 700 (71) 2 (2) < 0.001
) 1500 (0) 1020 (45) 810 (22) 2 (1)
) > 2000 (nc) 1480 (45) 569 (321) 2 (2) 0.031
) 5 (2) 3 (7) < 1 (nc) < 1 (nc)
) 980 (45) 760 (55) 11 (8) < 1 (nc) < 0.001
) 540 (89) 108 (16) < 1 (nc) < 1 (nc)
) 880 (27) 770 (45) 15 (12) < 1 (nc) < 0.001
) 42 (26) 11 (5) < 1 (nc) < 1 (nc)
) 350 (35) 306 (26) 3 (2) < 1 (nc) < 0.001
) 86 (15) 54 (15) 46 (12) 55 (22)
) 71 (10) 62 (15) 55 (4) 43 (9) 0.328
) 143 (38) 130 (25) 11 (7) < 1 (nc)
) 338 (24) 336 (32) 4 (4) < 1 (nc) < 0.001
43 (12) 28 (7) 11 (4) 4 (4)
) 41 (9) 41 (9) 34 (5) 2 (1) 0.061
eadwire sections were rolled on blood agar plates. Plate colonies were counted
coxon signed-rank test to determine statistical significance.
Colonies obtained from leadwires after contamination
with S. aureus Mu50 strain of







Figure 1 Colonies obtained from contaminated leadwires. At t0
and after 2, 4, 6, 24 and 48 hours of storage at 37°C, coated and
non-coated leadwire sections contaminated with Mu50
Staphylococcus aureus were rolled on blood agar plates and then
incubated for 48 hours at 37°C.
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month period preceding the study. We also tested two
fungi: Candida albicans and Aspergillus fumigatus.
Wires
Metalloacid-coated and non-coated EKG leadwires were
cut into sections 2 cm long. Groups of six sections of
coated and non-coated leadwires were placed into sterile
boxes. Before each microbial contamination, the pre-
packed wires were pasteurized at 65°C for one hour.
Contamination of leadwires
Microbial suspensions were prepared as follows: one col-
ony of a fresh culture on an agar plate was used to in-
oculate brain-heart infusion broth. After incubation for
24 hours at 37°C, the final microbial suspension was pre-
pared by adding 50 μL of the cultured broth to 100 mL
of sterile saline solution. Ten mL of each microbial sus-
pension was added to one test box containing the coated
leadwire sections and one control box containing non-
coated leadwire sections. The boxes were hermetically
sealed and then agitated gently for 15 minutes at ambi-
ent temperature. The leadwire sections were then trans-
ferred to sterile tubes (one per tube) and this was
defined as time 0 (t0). The samples were stored at 37°C
for various times.
Semi-quantitative assessment of microorganism survival
In account of the form of the leadwire sections used for
the study, we applied the semiquantative culture method
of Maki that is well-recognized method for evaluating
the microbial density colonization on catheter surface
[18]. At t0, and after two, four, six, 24 and 48 hours of
storage at 37°C, Maki’s technique was performed by
transferring each contaminated leadwire section to a
blood agar plate and by rolling the section back and
forth across the surface (one section per plate). The
plates were then incubated for 48 hours at 37°C. After
incubation, the plates were photographed and colonies
were counted. For each of the tested microorganisms,
the overall assay was repeated five times, and the bacter-
ial counts were used to calculate average counts.
Statistical analysis
Wilcoxon signed-rank tests were used to compare con-
tinuous paired data. For all calculations, a two-tailed
P value of less than 0.05 was considered to indicate stat-
istical significance. The software package Stata, version
10.0 (Stata Corp., College Station, TX, USA) was used
for analysis.
Results and discussion
The data obtained for the contaminated coated and
non-coated leadwire sections are reported in Table 1.Examples of plate cultures obtained from Mu50 S.
aureus-coated leadwires are shown in Figure 1. The
average colony counts obtained for the non-coated con-
trol wires after they were incubated for 2 − 48 hours
showed that all the microorganisms tested were able to
survive on the surface of the non-coated wires for pro-
longed periods of time (Table 1) (Figure 2). Culture of
these wires six hours after contamination revealed high
bacteria counts in all cases. At 24 hours, very high bac-
teria counts were detected for Gram-negative organisms.
At 48 hours, substantial numbers of bacteria colonies
were cultured from wires contaminated with most of the
Gram-negative microorganisms (i.e. the ESBL-producing
Enterobacteriaceae and P. aeruginosa) and with the two





































































































































Figure 2 Schematic representation of the antimicrobial activity of coated and non-coated surfaces contaminated with microorganisms.
Colony counts in average cfu obtained from wires 0− 48 hours after contamination with various microorganisms. Data are from five replicate experiments.
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C. difficile. In contrast, we detected survival of the two
staphylococci, E. faecium and C. albicans 24 hours after
contamination but never after 48 hours. Overall, these
first data confirmed the non-coated leadwire surface as a
stand for nosocomial pathogens, capable of harboring vi-
able microorganisms.
In contrast, the coated surfaces exhibited marked bio-
cidal activity, relative to that of the control surface,
against all non-spore-forming microorganisms tested
(Table 1). The biocidal effect of the coated surface dif-
fered with respect to the microorganisms in terms of
kinetics, intensity and final outcome. Nevertheless, bac-
terial counts after six to 24 hours of contact with the
coated surface were significantly lower than those
observed with non-coated surface (p <0.001). The bio-
cidal effect was the fastest against staphylococci and
E. faecium, as marked effects were detected after two
hours of contact. In contrast, the biocidal effect on
Gram-negative microorganisms took longer and was
generally evident after four hours. Of note, the spore-
forming microorganisms were completely unaffected by
the coated surfaces.
The acidic surface reaction is thought to be related to
the diffusion of H3O
+ ions through the microbial mem-
branes, resulting in altered enzymatic transport systems
and inhibition of key metabolic activities [17]. Thus, the
acidic-pH-associated biocidal effect produced by the
metalloacid-coated surface would be expected to have a
universal effect. The variations in susceptibility between
Gram-positive and Gram-negative microorganisms, and
the resistance exhibited by the spore-forming ones, sug-
gest that the differences among microorganisms with re-
spect to their susceptibility to the biocidal surface may
be due to the H3O
+ ion permeability of their cell wall
and/or cell membrane. In account of a biological cost of
antimicrobial resistance, MDR microorganisms may be
less fit and have slower growth rates than sensitive
strains [19]. Thus, further studies should be done with
wild isolates, to guaranty a biocide effect on them. Des-
pite these limitations, our data show that the survival of
non-spore-forming multidrug resistant microorganisms
was severely diminished on coated surfaces compared to
that on control surfaces. Considering the continuous
spread of microorganisms in the surroundings of
patients, the usual rhythm of cleaning procedures in
hospital wards, and the continuous biocidal effect of the
metalloacid-coated surface against the multidrug resist-
ant nosocomial pathogens, we suggest that coated device
surfaces may provide an permanent means of minimiz-
ing microbial contamination between two cleaning
procedures.
The mechanism of microorganism killing at pH values
<4.0 is non-specific [1]. Thus, in contrast to disinfectantsand antibiotics, microbial resistance to this mode of ac-
tion may not emerge as a result of exposure to MoO3.
In addition, cytotoxicity tests (MTT assays) and
thrombogenicity tests of the powder components sug-
gest that they should be safe for human use [16].
Conclusions
In view of these promising in vitro results, we suggest
that MoO3 coating may be an effective means of minim-
izing microorganism contamination on certain hospital
surfaces. Further studies are needed to evaluate the ben-
efits of this coating on medical devices that are fre-
quently touched by HCWs and to determine whether it
can be used as a complementary measure for the pre-
venting of the spread of microorganisms to sites near
patients in hospital settings.
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